Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
Helen Bygrave Great to see WHO moving forward with pre-qualification of biosimilar insulin. Really hoping we can get more competition and prices that reflect the cost of production of insulin !! #DiabetesinCrises @MSF_access @MSF_Zimbabwe who.int/news-room/deta… 02:10 - 13 Nov 2019